Scholarlink

Background <p>Eosinophils play an increasingly recognized role in chronic obstructive pulmonary disease (COPD). However, the optimal threshold for blood eosinophil (EOS) counts remains controversial. This study aimed to identify a clinically meaningful EOS threshold in acute exacerbations of COPD (AECOPD) and characterize patients with elevated EOS.</p> Methods <p>In this retrospective observational study, 1,406 AECOPD patients hospitalized were enrolled. Clinical data were analyzed, and receiver operating characteristic (ROC) curves were used to evaluate the optimal EOS threshold based on hospitalization costs. Patients were stratified by EOS levels (1.0%, 1.25%, 1.50%, 1.75%, 2.0%), and clinical characteristics were compared.</p> Results <p>Among enrolled patients, 83.3% were male, averaging 66.16&#xa0;years, with 71.5% having a smoking history, predominantly GOLD stage II. Median hospital stay was 8&#xa0;days, costing 9412.58 RMB. ROC analysis determined that&#xa0;a 1.0% EOS cutoff (AUC = 0.652, 95% CI: 0.626–0.677; Youden index = 0.2581, Z = 9.73, <i>P</i> &lt; 0.001)&#xa0;is&#xa0;the optimal threshold. Patients with EOS ≥ 1.0% were younger, incurred lower costs, and had shorter stays. They showed reduced sputum neutrophils and lymphocytes, elevated eosinophils, higher albumin, lower urea nitrogen and HbA1c, and less diabetes. Improved FEV<sub>1</sub>% and PEF, fewer ICU admissions, and reduced antibiotic and corticosteroid use were also observed.</p> Conclusion <p>This study identified that a cutoff value of 1.0% for peripheral blood EOS percentage more effectively reflects the clinical characteristics of patients with AECOPD associated with elevated peripheral blood EOS levels.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical Implications of a 1.0% Blood Eosinophil Threshold in Acute Exacerbations of COPD: a retrospective observational study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月25日

查看全文
  • Geyi Wen,
  • Jinliang Meng,
  • Yanyan Xu,
  • Ruiqi Wang

摘要

Background

Eosinophils play an increasingly recognized role in chronic obstructive pulmonary disease (COPD). However, the optimal threshold for blood eosinophil (EOS) counts remains controversial. This study aimed to identify a clinically meaningful EOS threshold in acute exacerbations of COPD (AECOPD) and characterize patients with elevated EOS.

Methods

In this retrospective observational study, 1,406 AECOPD patients hospitalized were enrolled. Clinical data were analyzed, and receiver operating characteristic (ROC) curves were used to evaluate the optimal EOS threshold based on hospitalization costs. Patients were stratified by EOS levels (1.0%, 1.25%, 1.50%, 1.75%, 2.0%), and clinical characteristics were compared.

Results

Among enrolled patients, 83.3% were male, averaging 66.16 years, with 71.5% having a smoking history, predominantly GOLD stage II. Median hospital stay was 8 days, costing 9412.58 RMB. ROC analysis determined that a 1.0% EOS cutoff (AUC = 0.652, 95% CI: 0.626–0.677; Youden index = 0.2581, Z = 9.73, P < 0.001) is the optimal threshold. Patients with EOS ≥ 1.0% were younger, incurred lower costs, and had shorter stays. They showed reduced sputum neutrophils and lymphocytes, elevated eosinophils, higher albumin, lower urea nitrogen and HbA1c, and less diabetes. Improved FEV1% and PEF, fewer ICU admissions, and reduced antibiotic and corticosteroid use were also observed.

Conclusion

This study identified that a cutoff value of 1.0% for peripheral blood EOS percentage more effectively reflects the clinical characteristics of patients with AECOPD associated with elevated peripheral blood EOS levels.